1. Home
  2. SLGL vs RFIL Comparison

SLGL vs RFIL Comparison

Compare SLGL & RFIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • RFIL
  • Stock Information
  • Founded
  • SLGL 1997
  • RFIL 1979
  • Country
  • SLGL Israel
  • RFIL United States
  • Employees
  • SLGL N/A
  • RFIL N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • RFIL Electrical Products
  • Sector
  • SLGL Health Care
  • RFIL Technology
  • Exchange
  • SLGL Nasdaq
  • RFIL Nasdaq
  • Market Cap
  • SLGL 69.1M
  • RFIL 68.7M
  • IPO Year
  • SLGL 2018
  • RFIL N/A
  • Fundamental
  • Price
  • SLGL $26.57
  • RFIL $7.56
  • Analyst Decision
  • SLGL
  • RFIL Strong Buy
  • Analyst Count
  • SLGL 0
  • RFIL 1
  • Target Price
  • SLGL N/A
  • RFIL $9.25
  • AVG Volume (30 Days)
  • SLGL 32.9K
  • RFIL 165.3K
  • Earning Date
  • SLGL 11-14-2025
  • RFIL 09-11-2025
  • Dividend Yield
  • SLGL N/A
  • RFIL N/A
  • EPS Growth
  • SLGL N/A
  • RFIL N/A
  • EPS
  • SLGL N/A
  • RFIL N/A
  • Revenue
  • SLGL $23,931,000.00
  • RFIL $76,353,000.00
  • Revenue This Year
  • SLGL N/A
  • RFIL $20.11
  • Revenue Next Year
  • SLGL $31.17
  • RFIL $5.95
  • P/E Ratio
  • SLGL N/A
  • RFIL N/A
  • Revenue Growth
  • SLGL 264.86
  • RFIL 22.60
  • 52 Week Low
  • SLGL $4.01
  • RFIL $3.39
  • 52 Week High
  • SLGL $30.00
  • RFIL $9.21
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 65.38
  • RFIL 53.91
  • Support Level
  • SLGL $23.15
  • RFIL $6.82
  • Resistance Level
  • SLGL $24.85
  • RFIL $7.58
  • Average True Range (ATR)
  • SLGL 2.32
  • RFIL 0.68
  • MACD
  • SLGL -0.41
  • RFIL 0.02
  • Stochastic Oscillator
  • SLGL 61.43
  • RFIL 57.09

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About RFIL RF Industries Ltd.

RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. Connector segment designs, manufactures, markets and distributes a broad range of RF connector, adapter, coupler, divider, and cable products etc. The Custom Cabling segment custom copper and fiber cable assemblies etc. The company operates in Canada, Italy, China, USA, UK.

Share on Social Networks: